Replies to post #9770 on Health Discovery Corp (HDVY)

[Stonemoney]

Hard to believe we sit at .14 after reading that Intro.

[chazzy]

Tryn2, I assume that you are already familiar with what I am about to say, but I think it needs to be said again for the sake of greater clarity, and for keeping things in perspective. The prostate urine test from Quest will precede any tests from Abbott. Quest is currently in the driver's seat with this test, and they are conducting their own double-blind* studies. When those studies are concluded, the results will be disclosed to all parties, and it is expected that the commercialization of the urine test will then be announced. There is no way to gauge how long Quest will take with this, but they are working very closely with the FDA, and it is in Quest's own best interest to independently confirm HDC's lab test results so that they can bring this test to market ASAP.

*Double-blind describes an especially stringent way of conducting an experiment, usually on human subjects, in an attempt to eliminate subjective bias on the part of both experimental subjects and the experimenters. In most cases, double-blind experiments are held to achieve a higher standard of scientific rigor.
In a double-blind experiment, neither the individuals nor the researchers know who belongs to the control group and the experimental group. Only after all the data has been recorded (and in some cases, analyzed) do the researchers learn which individuals are which. Performing an experiment in double-blind fashion is a way to lessen the influence of the prejudices and unintentional physical cues on the results (the placebo effect, observer bias, and experimenter's bias). Random assignment of the subject to the experimental or control group is a critical part of double-blind research design. The key that identifies the subjects and which group they belonged to is kept by a third party and not given to the researchers until the study is over.
Double-blind methods can be applied to any experimental situation where there is the possibility that the results will be affected by conscious or unconscious bias on the part of the experimenter.